Cti Biopharma Corp Receivables Turnover Ratio (CTIC), from the first quarter 2023 to the first quarter 2022 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cti Biopharma Corp   (NASDAQ: CTIC)
 

Cti Biopharma Accounts Receivables Turnover Ratio from the first quarter 2023 to the first quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Cti Biopharma Corp 's ability to collect accounts receivable sequentially worsen to 5.31, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Cti Biopharma 's Accounts Receivable average collection period in the Mar 31 2023 quarter, has increased to 69 days, from 62 days, in the Dec 31 2022 quarter.

If we take a look into Healthcare sector 408 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2023 from 2763 to 2810.

What is Receivable Turnover Ratio?
What is Cti Biopharma Corp Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CTIC Receivables Turnover Ratio (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Receivable Change 846.29 % - - - -
Y / Y Revenue Change 950.81 % - - - -
Receivable Turnover Ratio (TTM) 5.31 5.9 6.21 5.53 3.78
CTIC's Total Ranking # 2810 # 2763 # 0 # 0 # 0
Accounts Receivable average collection period days 69 62 59 66 96
Seq. Receivable Change 49.2 % 45.27 % 29.82 % 236.31 % -
Seq. Revenue Change 14.39 % 15.58 % 47.95 % 437.21 % -


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 139
Healthcare Sector # 409
Overall Market # 2810

Receivable Turnover Ratio Statistics
High Average Low
12275 579.55 5.31
(Sep 30 2018)   (Mar 31 2023)





CTIC Company Profile • Back to CTIC Efficiency Comparisons • Compare CTIC Receivables Turnover Ratio to its Competitors

Financial Statements
Cti Biopharma 's Accounts Receivable $ 23 Millions Visit CTIC's Balance sheet
Cti Biopharma 's Sales TTM $ 76 Millions Visit CTIC's Income Statement
Sources of CTIC's Revenues Visit CTIC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CTIC's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CTIC's Growth Rates CTIC's Roa CTIC's Inventory Turnover Ratio CTIC's Dividend Comparisons
CTIC's Profitability Ratios CTIC's Roi CTIC's Asset Turnover Ratio CTIC's Dividend Growth
CTIC's Valuation Ratios CTIC's Roe CTIC's Financial Strength Ratios CTIC's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2023 Receivable at quarter ending Mar 31 2023
Vbi Vaccines Inc  8.98 $ 1.441  Millions$ 0.161  Millions
Biolase Inc   8.90 $ 48.763  Millions$ 5.482  Millions
Adma Biologics Inc   8.89 $ 181.890  Millions$ 20.452  Millions
Harmony Biosciences Holdings inc   8.89 $ 471.668  Millions$ 53.051  Millions
Inspire Medical Systems inc   8.89 $ 466.371  Millions$ 52.468  Millions
Vanda Pharmaceuticals Inc   8.84 $ 256.688  Millions$ 29.046  Millions
Mannkind Corporation  8.82 $ 128.404  Millions$ 14.559  Millions
T2 Biosystems Inc   8.81 $ 17.149  Millions$ 1.946  Millions
Acadia Healthcare Company Inc   8.77 $ 2,817.622  Millions$ 321.290  Millions
Surmodics Inc   8.77 $ 102.973  Millions$ 11.747  Millions
Comera Life Sciences Holdings Inc   8.70 $ 0.931  Millions$ 0.107  Millions
Insmed Inc  8.69 $ 254.406  Millions$ 29.280  Millions
Henry Schein Inc   8.60 $ 12,528.000  Millions$ 1,457.000  Millions
Silk Road Medical Inc   8.52 $ 150.748  Millions$ 17.690  Millions
Traws Pharma inc   8.51 $ 0.217  Millions$ 0.026  Millions
Heska Corporation  8.47 $ 254.888  Millions$ 30.083  Millions
Adapthealth Corp   8.44 $ 3,009.018  Millions$ 356.515  Millions
Lifestance Health Group Inc   8.41 $ 909.036  Millions$ 108.069  Millions
Durect Corp  8.39 $ 19.422  Millions$ 2.314  Millions
Lite Strategy Inc   8.37 $ 58.773  Millions$ 7.022  Millions
Scientific Industries Inc   8.36 $ 11.117  Millions$ 1.329  Millions
Idexx Laboratories Inc  8.33 $ 3,430.970  Millions$ 411.904  Millions
Embecta Corp   8.31 $ 1,118.500  Millions$ 134.525  Millions
Anaptysbio Inc   8.30 $ 10.691  Millions$ 1.289  Millions
Ensign Group Inc  8.28 $ 3,198.864  Millions$ 386.393  Millions
Invacare Holdings Corporation  8.24 $ 706.226  Millions$ 85.695  Millions
Ardelyx inc   8.22 $ 63.059  Millions$ 7.671  Millions
Biodesix Inc   8.20 $ 40.720  Millions$ 4.967  Millions
Encision Inc   8.20 $ 7.349  Millions$ 0.897  Millions
Quidelortho Corp  8.16 $ 3,109.841  Millions$ 381.125  Millions

Date modified: 2026-08-29T17:19:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.